A phase II, randomized, double-blind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: A Gynecologic Oncology Group partners study

Saved in:

Bibliographic Details
Published in	Gynecologic oncology Vol. 145; pp. 220 - 221
Main Authors	Monk, B.J, Brady, M.F, Aghajanian, C, Lankes, H, Rizack, T, Leach, J.W, Fowler, J.M, Higgins, R.V, Hanjani, P, Morgan, M.A
Format	Journal Article
Language	English
Published	01.06.2017
Subjects	Hematology, Oncology and Palliative Medicine Obstetrics and Gynecology
Online Access	Get full text

Loading…

More Information
ISSN:	0090-8258
DOI:	10.1016/j.ygyno.2017.03.507